CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.290
-0.040 (-1.72%)
At close: May 16, 2025, 4:00 PM
2.310
+0.020 (0.87%)
After-hours: May 16, 2025, 4:00 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $25.79 million as of May 16, 2025. Its market cap has decreased by -0.67% in one year.
Market Cap
25.79M
Enterprise Value
22.49M
1-Year Change
-0.67%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $25.79M, a decrease of -44.07%. That is a compound annual growth rate of -24.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 25.79M | -34.26% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |